Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea · Delayed Price · Currency is KRW 141,500
+8,200 (6.15%)
At close: Feb 27, 2026
Mezzion Pharma Market Cap
Mezzion Pharma has a market cap or net worth of 4.3 trillion as of February 27, 2026. Its market cap has increased by 367.95% in one year.
Market Cap
4.30T
Enterprise Value
4.28T
Revenue
7.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
141,500.00
Market Cap Chart
Since January 20, 2012, Mezzion Pharma's market cap has increased from 240.02B to 4.30T, an increase of 1,690.48%. That is a compound annual growth rate of 22.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 4.30T | 57.09% |
| Dec 30, 2025 | 2.74T | 195.96% |
| Dec 30, 2024 | 924.37B | -19.89% |
| Dec 28, 2023 | 1.15T | 231.92% |
| Dec 29, 2022 | 347.65B | -82.01% |
| Dec 30, 2021 | 1.93T | 23.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.75T |
| Celltrion | 52.97T |
| ALTEOGEN | 21.55T |
| Sam Chun Dang Pharm. | 17.61T |
| SK bioscience | 3.91T |
| D&D Pharmatech | 3.87T |
| CLASSYS | 3.85T |
| PharmaResearch | 3.63T |